News

Lung cancer is currently the deadliest cancer in the US. An online guide and tool provider for physicians could help cut the rate.

A new study finds that age, gender, physician gender, income, and social behavior influence whether teenagers and young adults are confidential with their care providers.

A pilot study testing a multi-tasking game in children with autism and ADHD demonstrated feasibility, acceptability, and non-significant efficacy.

The 1100-patient study is comparing once-daily ponesimod and teriflunomide for patients with the relapsing form of the disease.

Dipanjan Basu, PhD, is testing non-melanoma drugs, like the investigational therapy omipalisib (GSK2126458) in cultured patient cells.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

The rate of palliative care in MS patients to have died in the hospital increased from 7.7% to 58.8% over 10 years ending in 2014.

The rate of youths using flavored tobacco products increased by nearly 7% from 2016 to 2017.

Patients treated with SAGE-217 had significantly improved depression scores and were more likely to achieve remission than those receiving placebo.

The 24-2 visual field test was comparably worse than other tests in consideration to glaucoma patients' central vision.

The FDA has approved RFPi Inc’s blood flow and perfusion imaging medical device, iCertainty.

A Norwegian-based study found that the risk of pediatric asthma increases in children of mothers who had experienced miscarriages early in pregnancy.

The fact that nearly 7 of every 10 Alzheimer diagnoses are made in women is not just associated with longer age expectancy.

A series of recently presented studies support the notion of treating hepatitis C in patients already on opioid substitution therapy.

A new method assessing the influenza A strain provides investigators a more detailed look at flu viruses.

The Second Chance app from University of Washington investigators is seeking FDA consideration in the near future.

Medical students’ perceptions of the barriers to applying for a dermatology residency vary based on race, ethnicity, and socioeconomic background.

Over 2 years, lacosamide was effective and generally well tolerated among adults with newly diagnosed epilepsy, compared to carbamazepine.

Lower respiratory tract infections linked to influenza were responsible for an estimated 145,000 deaths worldwide in 2017.

A recent longitudinal study assessment 3 decades of patient progress in Copenhagen found no significant association between BMI and airway hyperresponsiveness.

The reported rate of outpatient visits for influenza-like illness increased to 4.1%—well above the national baseline of 2.2%, and 1.5% greater than the rate reported midway through December.

The FDA has approved EyeBOX, the first non-invasive, baseline-free tool directed at diagnosing concussions.

The FDA has expanded approval for the Embrace smartband to be used by children aged 6 years and older with epilepsy.

A prior asthma exacerbation is associated with a 2.5-fold increase in the odds of a future severe exacerbation.

The ProAir Digihaler, from Teva, will reach the US markets widescale in 2020 after receiving FDA approval.

Crizanlizumab is being developed to prevent painful and unpredictable vaso-occlusive crises in patients with sickle cell disease.

Canadian investigators identified the role of media in both promulgating and mitigating stigma of PrEP for preventing HIV transmission.